Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanting Ding

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Medicine|August 19, 2025
Uterine torsion with fetal death in the third trimester: Case reportLinghui Liu, Min Zhou, Yanting Ding
Annals of Medicine|March 8, 2023
Emergency decompression for patients with ureteral stones and SIRS: a prospective randomized clinical studyXiaofei Lu, Benzheng Zhou, Dechao Hu, et al.
Current Pharmaceutical Design|November 13, 2018
Advances in Antidiabetic Drugs Targeting Insulin SecretionYanting Ding, Yilian Li, Qin Chen, et al.
European Journal of Pharmacology|November 8, 2022
Loureirin B promotes insulin secretion through GLP-1R and AKT/PDX1 pathwaysHaowen Fang, Yanting Ding, Sijing Xia, et al.
European Journal of Pharmacology|September 5, 2021
Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathwayYanting Ding, Sijing Xia, Haowen Fang, et al.
BMJ Open|June 12, 2024
Efficacy and safety of transcutaneous electrical acupoint stimulation for the management of primary dysmenorrhoea: protocol for a randomised controlled trial in ChinaWeiting Liu, Yanting Ding, Honggang Xie, et al.
Cellular Signalling|April 6, 2025
Loureirin B analogs mitigate oxidative stress and confer renal protectionHaowen Fang, Xiaodong Sun, Yanting Ding, et al.
Journal of Cellular and Molecular Medicine|December 10, 2020
Loureirin B activates GLP-1R and promotes insulin secretion in Ins-1 cellsYanting Ding, Sijing Xia, Han Zhang, et al.
International Journal of Molecular Sciences|December 11, 2025
From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 ReceptorHaowen Fang, Xiaodong Sun, Yanting Ding, et al.
Current Pharmaceutical Design|May 16, 2023
Study on the Interaction between Silibinin and NeuraminidaseHaowen Fang, Yanting Ding, Yi Lu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Medicine|August 19, 2025
Uterine torsion with fetal death in the third trimester: Case reportLinghui Liu, Min Zhou, Yanting Ding
Annals of Medicine|March 8, 2023
Emergency decompression for patients with ureteral stones and SIRS: a prospective randomized clinical studyXiaofei Lu, Benzheng Zhou, Dechao Hu, et al.
Current Pharmaceutical Design|November 13, 2018
Advances in Antidiabetic Drugs Targeting Insulin SecretionYanting Ding, Yilian Li, Qin Chen, et al.
European Journal of Pharmacology|November 8, 2022
Loureirin B promotes insulin secretion through GLP-1R and AKT/PDX1 pathwaysHaowen Fang, Yanting Ding, Sijing Xia, et al.
European Journal of Pharmacology|September 5, 2021
Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathwayYanting Ding, Sijing Xia, Haowen Fang, et al.
BMJ Open|June 12, 2024
Efficacy and safety of transcutaneous electrical acupoint stimulation for the management of primary dysmenorrhoea: protocol for a randomised controlled trial in ChinaWeiting Liu, Yanting Ding, Honggang Xie, et al.
Cellular Signalling|April 6, 2025
Loureirin B analogs mitigate oxidative stress and confer renal protectionHaowen Fang, Xiaodong Sun, Yanting Ding, et al.
Journal of Cellular and Molecular Medicine|December 10, 2020
Loureirin B activates GLP-1R and promotes insulin secretion in Ins-1 cellsYanting Ding, Sijing Xia, Han Zhang, et al.
International Journal of Molecular Sciences|December 11, 2025
From Phytochemistry to Metabolic Regulation: The Insulin-Promoting Effects of Loureirin B Analogous to an Agonist of GLP-1 ReceptorHaowen Fang, Xiaodong Sun, Yanting Ding, et al.
Current Pharmaceutical Design|May 16, 2023
Study on the Interaction between Silibinin and NeuraminidaseHaowen Fang, Yanting Ding, Yi Lu, et al.
Pageof 3